A clinical trial of MD-805, a synthetic thrombin inhibitor, for the treatment of DIC.
D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008590:Meningoencephalitis / Q000150:complications; D010314:Partial Thromboplastin Time; D010875:Pipecolic Acids / Q000627:therapeutic use*; D010976:Platelet Count; D011517:Prothrombin Time; D011552:Pseudomonas Infections / Q000150:complications; D018805:Sepsis / Q000150:complications; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*
D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D005340:Fibrinogen; D001120:Arginine; D013917:Thrombin; C031942:argatroban